Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2003
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP0946538B1 Indane or dihydroindole derivatives
08/06/2003EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0799209B1 Sulfonamides
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434792A Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434724A Remedies and/or preventives for nervous system disorders
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434709A Remedies for diseases due to stenotic lesions of blood vessel
08/06/2003CN1434707A Method and compositions for preventing hormone induced adverse effects
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1434702A Novel forms of pravastatin sodium
08/06/2003CN1434121A Fermentation production technology for olry bacterial powder containing gama-linolenic acid
08/06/2003CN1434055A Platelet glucoprotein receptor inhibitor, medicinal composition containing same and use thereof
08/06/2003CN1434042A Cattail pollen extract and preparation process and use thereof
08/06/2003CN1433808A Compound prunella spike capsule and preparation process thereof
08/06/2003CN1433769A Boping capsule preparation for treating cardiovascular and cevebrovascnlar disease and preparation process thereof
08/06/2003CN1433768A Flavone Hippophaes slow-released, control-redeased agent
08/06/2003CN1433766A Medicine for treating metabolism syndrome
08/06/2003CN1433761A Piperazine ferulate slow-released, control-released agent
08/06/2003CN1117154C Urokinase zymogen mutant
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1116894C Medicine for treating cardiovascular disease
08/06/2003CN1116885C Medicine for treating piles
08/06/2003CN1116884C Capsule for treating angiocardiopathy, cholecystitis and cholelithiasis
08/06/2003CN1116871C Pharmaceutical compositions and containing S-alkylisothiouronium derivatives
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603006 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use
08/05/2003US6602984 Human elastase IV
08/05/2003US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602893 Amide derivative of amlodipine
08/05/2003US6602881 Anti-inflammatory uses of manzamines
08/05/2003US6602880 3-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmia
08/05/2003US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
08/05/2003US6602876 Adhesion receptor antagonists
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602866 Mercaptoacetylamide derivatives, a process for their preparation and their use
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602863 Irreversible inhibitors of tyrosine kinases
08/05/2003US6602854 Branched multimeric Apo A-I agonist compounds
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602274 Targeted transcutaneous cancer therapy
08/05/2003US6601580 Enhancing therapeutic effectiveness of nitric oxide inhalation
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062416A1 Method of screening preventive and remedy for arteriosclerosis
07/31/2003WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells
07/31/2003WO2003062392A2 Methods of treating conditions associated with an edg receptor
07/31/2003WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062247A2 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace)
07/31/2003WO2003062243A1 Novel compounds as semaphorin inhibitors
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062227A1 Rho-kinase inhibitors
07/31/2003WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors
07/31/2003WO2003062220A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062206A2 Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
07/31/2003WO2003062203A1 Method
07/31/2003WO2003062201A1 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
07/31/2003WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
07/31/2003WO2003062189A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
1 ... 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 ... 1595